CWA Asset Management Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.52M | Buy |
|
|||||
|
2025
Q2 | $1.18M | Buy |
|
|||||
|
2025
Q1 | $857K | Buy |
|
|||||
|
2024
Q4 | $548K | Sell |
|
|||||
|
2024
Q3 | $1.91M | Buy |
|
|||||
|
2024
Q1 | $1.01M | Sell |
|
|||||
|
2023
Q4 | $921K | Sell |
|
|||||
|
2023
Q3 | $918K | Buy |
|
|||||
|
2023
Q2 | $854K | Buy |
|
|||||
|
2023
Q1 | $826K | Buy |
|
|||||
|
2022
Q4 | $697K | Buy |
|
|||||
|
2022
Q3 | $554K | Buy |
|
|||||
|
2022
Q2 | $979K | Buy |
|
|||||
|
2022
Q1 | $947K | Buy |
|
|||||
|
2021
Q4 | $695K | Hold |
|
|||||
|
2021
Q3 | $602K | Sell |
|
|||||
|
2021
Q2 | $652K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $291K | Sell |
|
|||||
|
2019
Q3 | $285K | Sell |
|
|||||
|
2019
Q2 | $268K | Sell |
|
|||||
|
2019
Q1 | $281K | Sell |
|
|||||
|
2018
Q4 | $272K | Buy |
|
|||||
|
2018
Q3 | $234K | Sell |
|
|||||
|
2018
Q2 | $273K | Sell |
|
|||||
|
2018
Q1 | $280K | Buy |
|
|||||
|
2017
Q4 | $202K | Hold |
|
|||||
|
2017
Q3 | $232K | Buy |
|
|||||
|
2017
Q2 | $234K | Sell |
|
|||||
|
2017
Q1 | $266K | Buy |
|
|||||
|
2016
Q4 | $215K | Sell |
|
|||||
|
2016
Q3 | $273K | Buy |
|
|||||
|
2016
Q2 | $270K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $266K | Buy |
|